User's Guide
9
Introduction 1
Warning: If you are having symptoms that are not consistent with your
blood glucose test results and you have followed all instructions described in
this User Guide, contact your healthcare provider.
Warning: e Omnipod 5 System should NOT be used at low atmospheric
pressure (below 700 hPA). You could encounter such low atmospheric
pressures at high elevations, such as when mountain climbing or living at
elevations above 10,000 feet (3,000 meters).
Warning: e Omnipod 5 System should NOT be used in oxygen rich
environments (greater than 25% oxygen) or at high atmospheric pressure
(above 1060 hPA), both of which can be found in a hyperbaric chamber.
Hyperbaric, or high pressure, chambers are sometimes used to promote
healing of diabetic ulcers, or to treat carbon monoxide poisoning, certain
bone and tissue infections, and decompression sickness.
Warning: Do NOT attempt to use the Omnipod 5 System before you receive
training. Inadequate training could put your health and safety at risk.
Caution: Do not navigate away from the Omnipod 5 app while you are in
the process of making changes to your insulin delivery programs. A phone
call or other distraction may cause you to miss an important alarm or update,
putting you at risk of developing hypoglycemia or hyperglycemia. If you are
unsure about the insulin therapy being provided or about messages sent by your
Omnipod 5 app, review your alarms, your Home screen and your history records.
Potential benets
e benets of the Omnipod 5 Automated Insulin Delivery System may include:
• Adjusting insulin delivery based on CGM value and trend in order to reduce
the duration of hypoglycemia and hyperglycemia and increase time spent in
normal glycemic range.
• Keeping glucose levels in range on a daily basis aids in preventing both short-
term (e.g. hypoglycemia, hyperglycemia) and long term complications.
• Continuous insulin delivery without the need to disconnect prevents elevated
glucose levels caused by short-term interruptions.
• Rotation of insulin infusion sites aids in prevention of infusion site
complications.
Before You
Begin
Effective Date: 22DEC2020, PCO-000267